Evidence map›Paper›PMID 30880930›Full record

ArticleClinical interventions in aging2019

The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis.

Jacek Staszewski, Aleksandra Pogoda, Kamila Data, Klaudia Walczak, Maciej Nowocień, Emilia Frankowska, Adam Stępień

Open access · goldAbstract read
In one paragraph

Article in Clinical interventions in aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jacek StaszewskiClinic of Neurology, Military Institute of Medicine, Warsaw, Poland, jacekstaszewski@wp.pl.
Aleksandra PogodaClinic of Neurology, Military Institute of Medicine, Warsaw, Poland, jacekstaszewski@wp.pl.
Kamila DataClinic of Neurology, Military Institute of Medicine, Warsaw, Poland, jacekstaszewski@wp.pl.
Klaudia WalczakClinic of Neurology, Military Institute of Medicine, Warsaw, Poland, jacekstaszewski@wp.pl.
Maciej NowocieńDepartment of Radiology, Military Institute of Medicine, Warsaw, Poland.
Emilia FrankowskaDepartment of Radiology, Military Institute of Medicine, Warsaw, Poland.
Adam StępieńClinic of Neurology, Military Institute of Medicine, Warsaw, Poland, jacekstaszewski@wp.pl.
National Academy of Medicine · USWojskowy Instytut Medycyny Lotniczej · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe role of biomarkers in the prediction of acute ischemic stroke (AIS) outcome or response to thrombolytic therapy (with recombinant tissue plasminogen activator [rt-PA]) remains limited. The aim of this study was to evaluate whether mean platelet volume (MPV) could predict short-term functional outcome in patients with AIS following rt-PA treatment. PATIENTS AND

methodsThis was a retrospective analysis of 237 AIS patients (mean age 71.04±0.8 years, 50.6% women) consecutively admitted to a tertiary care center between 2011 and 2015.

resultsThe mean MPV in the cohort was 9.8±0.35 fL (lowest tertile <7.29 fL, median 7.29-8.8 fL, and highest tertile >8.8 fL). Patients in the lowest tertile compared to median and highest tertiles were less often dependent (modified Rankin scale [mRS] ≥3) at admission (87.2% vs 96.1% and 96.1%, respectively,

conclusionDisabling or fatal ischemic stroke in thrombolyzed patients was observed more often in patients with high admission MPV. The prognostic value of MPV was independent of other well-defined individual risk factors.

Indexed as

Mean Platelet VolumeThrombolytic TherapyAcute DiseaseAgedAged, 80 and overBiomarkersBrain IschemiaFemaleFibrinolytic AgentsHumansMaleMiddle AgedPatient AdmissionPredictive Value of TestsPrognosisRetrospective StudiesBiomarkersFibrinolytic AgentsTissue Plasminogen Activatoracute ischemic strokebiomarkerMPVplatelet activityprognosisreperfusionrt-PA

Identifiers

PMID30880930
PMCPMC6398411
OpenAlexW2915821179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.